drugset / Trial / NCT01010139
Pharmacokinetic and Comparative Bioavailability Study of Codeine Sulfate Under Fasted Conditions
RandomizedCrossoverOpen-labelTreatment
Summary
The objective of this study designed to characterize the pharmacokinetics and comparative bioavailability of Roxane Laboratories' codeine sulfate tablets after oral administration of 60 mg doses as 1 x 60 mg, 2 x 30 mg and 4 x 15 mg under fasted conditions.
Timeline
- Start
- 2006-08
- Primary completion
- 2006-09
- Completion
- 2006-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Codeine | Small molecule | 60 mg | Oral |
Indications
No indication recorded.